Insulet, Mayo Clinic get in on Glooko’s $35m Series C round

June 27, 2017 By Brad Perriello Leave a Comment

Insulet (NSDQ:PODD) and Mayo Clinic were among the new investors to get in on a $35 million Series C round for Glooko and its diabetes management platform.

The round was led by new investor Georgian Partners, joined by Insulet and Mayo Clinic and existing backers Medtronic, Samsung, Canaan Partners and Social Capital, Mountain View, Calif.-based Glooko said. The proceeds are earmarked for expanding the company’s sales, marketing and development teams; boosting its commercial footprint in France, Germany, the U.K., Asia and the Middle East; and data analytics and AI development projects.

Glooko’s platform is designed to integrate data from blood glucose monitors and other devices with either an Apple (NSDQ:AAPL) iPhone or Google (NSDQ:GOOG) Android application. Food intake, medication and insulin dosage can also be recorded to provide context for changes in blood glucose readings. Data from meters and devices is sent to Glooko’s cloud-based Population Tracker, where patients and providers alike can view and analyze the data, and make decisions about interventions and treatments.

“This additional funding will help us to further our mission: to improve the lives of people with diabetes,” CEO Rick Altinger said in prepared remarks. “With this capital, we will accelerate our investments in clinical solutions that aim to increase medication adherence, provide personalized insights and prompts that drive behavior change for people with diabetes, and deliver clinical decision support to thousands of clinicians and coaches so they can better support people with diabetes in between office visits.”

“Glooko has demonstrated great traction and growth. Its scalable, device-agnostic platform not only meets the needs of people with diabetes, it also benefits health insurance plans, employers, pharma and health systems that want to effectively manage large populations of people with diabetes,” added Georgian Partners managing director Simon Chong. “We are excited to become a part of the Glooko investment team, working with Glooko on its analytics-driven approach to delivering both personal and clinical support to the diabetes community.”

Glooko, which raised a $17 million Series B round in March 2015, merged with Diasend in September 2016. Insulet and Glooko are not newfound friends; in January last year Insulet launched a Glooko-linked data management system for its OmniPod insulin management device.

Only a Few More Days to Register for the most anticipated conference of the winter!

DeviceTalks West is just a few days away. Join more than 300 of your peers for a day of world-class education, networking, and a technology exhibition featuring the leading companies in the industry.

Don’t miss out on this premier opportunity to come together and share perspectives with the best of the best in the industry.

REGISTER NOW

Use code LASTCHANCE to save an additional 20%.

Renerva lands $2.4 million to develop ‘Neosporin of nerve repair’
Nerve-repair startup Renerva said today it has received $2.4 million in funding from the U.S. Department of Defense. The Pittsburgh company is developing a periheral nerve matrix (PNM), an injectable gel derived from porcine tissue to help repair and regenerate injured peripheral nerves. The Medical Technology Enterprise Consortium (MTEC) Award award will enable Renerva to complete its preclinical… […]
Here’s how Intuitive Surgical is innovating to stay competitive
Intuitive Surgical (NSDQ:ISRG) isn’t resting on its laurels when it comes to the surgical robotics field that it dominates. The Sunnyvale, Calif.–based company is seeking to stay competitive through technologies including computer-controlled navigated robotic catheters, contrast agents to improve imaging during procedures, and intelligent surgical interfaces. That was a big message that hundreds of attendees heard during… […]
Will Acelity go public again?
Privately held Acelity may go public again, according to news reports this week. London-based Apax Partners and a pair of Canadian pension funds acquired wound-care company Kinetic Concepts Inc. (now Acelity) for $6.1 billion in a leveraged buyout in 2011. Apax is now mulling an initial public offering for Acelity by mid-2019, Bloomberg and the San Antonio Express-news reported.… […]
Okay Industries hires director of application development
Okay Industries announced that it has appointed John Kollar as the new director of application development. He will be based at the company’s New Britain, Conn. headquarters. Kollar will be responsible for supporting product engineering and development, as well as leading the expansion of the company into plastic molding capabilities. “We are excited to welcome… […]
Qosina launches e-commerce website redesign
Qosina has launched a newly redesigned e-commerce website that improves navigation and access. The company announced that the new website offers easier access to Qosina’s products and services. It features an updated product category structure, category-specific filtering to find components easily and downloadable documentation like safety data sheets, technical data sheets and compatibility information. “Our… […]
All Sensors adds pressure ranges to its compact sensor series
All Sensors (Morgan Hill, Calif.) said it has introduced additional pressure ranges to its BLC series. Applications for the series include medical devices, medical instruments and portable/hand held devices. The series now includes high-pressure ranges from 5 psi to 150 psi, offering design engineers performance for pressure ranges of ±1 inH2O through ±30 inH2O, and now 5 psi… […]
Synopsys releases new version of Simpleware
Synopsys (Mountain View, Calif.) has released a new version of its Simpleware 3D data visualization software, which is used in both life science and advanced materials and manufacturing applications. Improvements in the new Simpleware (Version O-2018.12) include: An intelligent number formatting system for better clarity of measurements and statistics. Refreshed icons for more efficient navigation of… […]
Solar Atmospheres hires new sales manager
Solar Atmospheres recently announced that it has hired Mike Paponetti as a sales manager at the company’s South Carolina facility. Paponetti will be responsible for leading sales efforts to maintain and promote sales for Solar Atmosphere in the Southeastern U.S. Prior to joining Solar Atmospheres’s South Carolina facility, Paponetti was regional sales manager at the… […]
Excelitas Technologies to buy Axsun Technologies
Excelitas Technologies (Waltham, Mass.) – a global provider of high-performance photonics – said today that it has signed a definitive agreement to acquire Axsun Technologies. Axsun (Billerica, Mass.) is a privately-held company that develops and produces MEMS-based light engines for high-performance medical imaging and industrial spectroscopy applications. Financial terms of the agreement were not disclosed. The deal… […]
November 2018 Special Edition: Women in Medtech
Lessons learned from top women leaders in medtech According to the Center for American Progress, women account for 47% of the country’s labor force and 52% of all professional-level jobs. The Equal Employment Opportunity Commission reports that just 20% of U.S. high-tech executives, senior officers and management are women, including pharmaceutical and medicine manufacturing and… […]
121nexus rebrands as Soom
121nexus recently announced that it is rebranding to Soom. As part of the rebranding, the company is also going to exclusively focus on the healthcare industry in its services. “Soom, meaning ‘breath,’ encapsulates all that the company stands for. Like a breath of fresh air, we’re rethinking how the healthcare industry uses proven technologies like… […]